Dexcom DXCM Earnings Call Transcripts

NASDAQ DXCM
$79.92 -1.15 (-1.42%)
At close: Nov 10, 2026 · 4:00 PM EST
27 earnings calls on file for Dexcom, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Dexcom Q3 2026 Earnings Call

Oct 29, 2026 10,400 words · 45 min read
  • Sean ChristensenSenior Vice President of Finance and Investor Relations
  • Jacob LeachPresident and Chief Executive Officer
  • Jereme SylvainChief Operating Officer and Chief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Dexcom Earnings Call Transcripts

Calls27
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 27 Dexcom transcripts Register to get access to Dexcom’s earnings call transcripts.